Morgan Stanley’s Columbia Research Enhanced Value ETF REVS Stock Holding History
Bought
Maintained
Sold
Other funds holding REVS
USCWA
NA
SPIA
RA
WIA
Morgan Stanley's REVS Position: Q1 2026 in Review
Morgan Stanley reduced its Columbia Research Enhanced Value ETF (REVS) stake by 11% in Q1 2026, selling an estimated $11.1K and leaving 3,019 shares worth $86.4K. The position accounts for ﹤0.01% of the portfolio, ranked #6223.
Morgan Stanley first reported a position in REVS in Q2 2022 and has held it in 16 quarters since. The position peaked at $96.2K in Q4 2025. 37 funds tracked by Wall St. Rank hold REVS as of Q1 2026.
- Morgan Stanley held 3,019 shares of Columbia Research Enhanced Value ETF worth $86.4K as of Q1 2026.
- Morgan Stanley sold 381 Columbia Research Enhanced Value ETF shares in Q1 2026, an estimated $11.1K.
- Columbia Research Enhanced Value ETF made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #6223 holding.
- Morgan Stanley first reported a position in Columbia Research Enhanced Value ETF in Q2 2022 and has held it in 16 quarters since.
- Morgan Stanley's Columbia Research Enhanced Value ETF position peaked at $96.2K in Q4 2025.
- 37 funds tracked by Wall St. Rank held Columbia Research Enhanced Value ETF as of Q1 2026.
Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.